Skip to main content
. 2018 Sep 6;2018:7176040. doi: 10.1155/2018/7176040

Table 10.

IC50 of some tested compounds against liver (HepG2), breast (MCF-7), and colon (HCT116) cancer cell lines.

Cell type IC50 (µg/ml)
L1 VO(II)-L1 L2 VO(II)-L2 L3 VO(II)-L3 L4 VO(II)-L4 L5 VO(II)-L5 Doxorubicin
MCF-7 19.68 23.06 25.92 93.92 15.50 >100 24.96 3.42 11.44 >100 0.60
HepG2 19.79 19.94 27.23 55.67 11.01 >100 28.25 1.27 9.91 >100 0.34
HCT116 19.15 22.93 13.27 95.17 15.53 >100 26.24 1.66 23.30 >100 0.39